Proneuron Biotechnologies

About:

Proneuron Biotechnologies develops spinal cord injury treatments, researches cures for paralysis, and neurological therapies.

Website: http://www.proneuron.com

Top Investors: Teva Pharmaceuticals, Pitango VC, Giza Venture Capital

Description:

Total Funding Amount:

$10M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

1996-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2001-12-31

IPO Status:

Private

Industries: